# Sana Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sana-biotechnology

- Industry: Biotechnology
- Headquarters: Seattle, US
- Website: www.sana.com
- Total disclosed funding: $867M
- Latest round: Series B (Feb 13, 2019)
- Investors on record: 11

## About

Founded in 2018 and based in the US, Sana Biotechnology, Inc. is a biotechnological company that develops engineered cells as medicines and therapies to treat diseases.

The firm has 3 ways to treat a patient with untreated diseases. First, repair and control genes in any cell. Second, Replace any cell in the body. Third, Tear down barriers to accessing the therapies.

## Funding rounds

- Series B, Feb 13, 2019, $821M — ARCH Venture Partners, Flagship Pioneering, Alaska Permanent Fund Corporation, CPP Investment Board, Public Sector Pension Investment Board, F-Prime Capital, Altitude Life Science Ventures, Baillie Gifford, GV, Omega Funds, Bezos Expeditions
- Series A, Oct 2, 2018, $46M — ARCH Venture Partners, Flagship Pioneering, F-Prime Capital

## Investors

- ARCH Venture Partners (https://capitalatlas.ai/funds/arch-venture-partners) — Series A, Series B
- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A, Series B
- F-Prime Capital (https://capitalatlas.ai/funds/f-prime-capital) — Series A, Series B
- Alaska Permanent Fund Corporation — Series B
- CPP Investment Board — Series B
- Public Sector Pension Investment Board — Series B
- Altitude Life Science Ventures (https://capitalatlas.ai/funds/altitude-life-science-ventures) — Series B
- Baillie Gifford (https://capitalatlas.ai/funds/baillie-gifford) — Series B
- GV (https://capitalatlas.ai/funds/gv) — Series B
- Omega Funds (https://capitalatlas.ai/funds/omega-funds) — Series B
- Bezos Expeditions — Series B